Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Humby

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Nature Communications|March 17, 2024
Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritisAlessandra Nerviani, Marie-Astrid Boutet, Giulia Maria Ghirardi, et al.
Plos One|March 1, 2018
Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progressionYanxia Guo, Alice M Walsh, Mary Canavan, et al.
Annals of the Rheumatic Diseases|August 22, 2018
Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody productionFelice Rivellese, Daniele Mauro, Alessandra Nerviani, et al.
Nature Medicine|May 19, 2022
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trialFelice Rivellese, Anna E A Surace, Katriona Goldmann, et al.
RMD Open|November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across EuropeSøren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Arthritis Research & Therapy|December 21, 2018
Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy GroupsAurélie Najm, Benoît Le Goff, Carl Orr, et al.
Arthritis Research & Therapy|December 5, 2018
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy GroupsAurélie Najm, Benoît Le Goff, Carl Orr, et al.
Lancet (London, England)|January 24, 2021
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Patrick Durez, Maya H Buch, et al.
Annals of the Rheumatic Diseases|March 18, 2019
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patientsFrances Humby, Myles Lewis, Nandhini Ramamoorthi, et al.
Annals of the Rheumatic Diseases|December 20, 2016
EULAR definition of arthralgia suspicious for progression to rheumatoid arthritisHanna W van Steenbergen, Daniel Aletaha, Liesbeth J J Beaart-van de Voorde, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nature Communications|March 17, 2024
Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritisAlessandra Nerviani, Marie-Astrid Boutet, Giulia Maria Ghirardi, et al.
Plos One|March 1, 2018
Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progressionYanxia Guo, Alice M Walsh, Mary Canavan, et al.
Annals of the Rheumatic Diseases|August 22, 2018
Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody productionFelice Rivellese, Daniele Mauro, Alessandra Nerviani, et al.
Nature Medicine|May 19, 2022
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trialFelice Rivellese, Anna E A Surace, Katriona Goldmann, et al.
RMD Open|November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across EuropeSøren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Arthritis Research & Therapy|December 21, 2018
Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy GroupsAurélie Najm, Benoît Le Goff, Carl Orr, et al.
Arthritis Research & Therapy|December 5, 2018
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy GroupsAurélie Najm, Benoît Le Goff, Carl Orr, et al.
Lancet (London, England)|January 24, 2021
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Patrick Durez, Maya H Buch, et al.
Annals of the Rheumatic Diseases|March 18, 2019
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patientsFrances Humby, Myles Lewis, Nandhini Ramamoorthi, et al.
Annals of the Rheumatic Diseases|December 20, 2016
EULAR definition of arthralgia suspicious for progression to rheumatoid arthritisHanna W van Steenbergen, Daniel Aletaha, Liesbeth J J Beaart-van de Voorde, et al.
Pageof 6